Phase 1 Clinical Trial Design The primary objective of this Phase 1 randomized, double-blind, placebo-controlled, multi-part single and multiple ascending dose clinical study is to evaluate the safety ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 monthsBiomarker analysis confirms immune activatio ...

Spyre Therapeutics (SYRE) Company Description: Aeglea Biotherapeutics, Inc. operates as a clinical-stage biotechnology ... Its product pegzilarginase, is in a Phase 3 pivotal trial for the treatment ...

“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed ...

In this instalment of our renewed clinical trials round-ups, we look at life sciences research and development announced during the week of 20th to 24th May, from early-stage onwards. During this ...

Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...

Although it is not without limitations, it provides a model for future response-adapted clinical trials. In the dose-escalation part of the ongoing phase 1/2 LIBRA4 trial, patients with relapsed ...